Blocking serotonin receptors makes eye cancer cells sensitive to drugs
By studying G protein–coupled receptor (GPCR) signaling in a range of uveal melanoma cell lines, Jenna Aumiller and colleagues have discovered a way to make these cells more sensitive to compounds that inhibit cancer-linked (or oncogenic) signaling pathways.
Read original article on The Medical News →Related news
-
Thalamic responsive neurostimulation reduces seizures by over 80% in pediatric patients
United Kingdom
-
New 'FITdb' database reveals the genetic drivers of immune cell function
United Kingdom
-
New review of the first oral PCSK9 drug, a needle-free option for high cholesterol
United Kingdom
-
Long travel distances linked to higher pediatric surgery complication risks
United Kingdom
-
Prenatal cannabis use disorder linked to higher postpartum psychiatric emergency visits
United Kingdom
-
For your health—the large and growing benefits of being smoke-free
United Kingdom
-
Drug ads can influence AI treatment recommendations, study finds
United Kingdom
-
Cataract surgery boosts work, income, and food security in Mozambique
United Kingdom